RIFAXIMIN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

 Table of Contents

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Global Rifaximin Market, By Indication
     • Global Rifaximin Market, By Dosage Form
     • Global Rifaximin Market, By Strength
     • Global Rifaximin Market, By Patient Group
     • Global Rifaximin Market, By End User
     • Global Rifaximin Market, By Manufacturer Category
     • Global Rifaximin Market, By Distribution Channel
     • Global Rifaximin Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
   • Driver
   • Restraint
   • Opportunity
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
   • Industry Trends

4. Global Rifaximin Market, By Indication, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Hepatic Encephalopathy (HE)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Irritable Bowel Syndrome with Diarrhea (IBS-D)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Traveler’s Diarrhea
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Small Intestinal Bacterial Overgrowth (SIBO)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Inflammatory Bowel Disease–Associated Diarrhea (IBD-D)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Clostridioides difficile–Associated Diarrhea (adjunct use)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Other Gastrointestinal Infections
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Rifaximin Market, By Dosage Form, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Tablet
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Oral Suspension
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Rifaximin Market, By Strength, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • 200 mg
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • 400 mg
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • 550 mg
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Rifaximin Market, By Patient Group, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Adult
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Geriatric
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Pediatric
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Rifaximin Market, By End User, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Hospitals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Gastroenterology Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Ambulatory Surgical Centers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Academic and Research Institutes
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Home Healthcare Providers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Rifaximin Market, By Manufacturer Category, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Branded
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Generic
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Rifaximin Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

11. Global Rifaximin Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturer Category, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturer Category, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturer Category, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturer Category, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturer Category, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturer Category, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa

12. Competitive Landscape

    • Salix Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bausch Health Companies Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alfasigma SpA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Lupin Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Aurobindo Pharma Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Cipla Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Cosmo Pharmaceuticals NV
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Zambon Company SpA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Granules India Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alembic Pharmaceuticals Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Macleods Pharmaceuticals Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • MSN Laboratories Pvt Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Hetero Drugs
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

13. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

14. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Rifaximin Market' - Global forecast to 2033